Company Filing History:
Years Active: 2024
Title: The Innovations of Timothy Frank Ryder
Introduction
Timothy Frank Ryder is an accomplished inventor based in Groton, Connecticut. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target various diseases.
Latest Patents
Ryder holds a patent for "Metabolites of GLP1R agonists." This invention provides compounds of Formula XA-1, XA-2, XA-3, XA-4, XA-5, or XA-6, or metabolites of Compound 1 or metabolites of a compound of Formula I, PA-I, or PA-III. These compounds are useful in the prevention and/or treatment of diseases such as Type 2 Diabetes Mellitus (T2DM), obesity, or Non-Alcoholic Steatohepatitis (NASH). The patent also includes analytical methods related to the administration of these compounds.
Career Highlights
Timothy Ryder is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His work focuses on innovative solutions that address critical health issues. Ryder's expertise in pharmacology and his dedication to research have positioned him as a valuable asset in the industry.
Collaborations
Ryder has collaborated with notable colleagues, including Andrew John Bessire and David Edmonds. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking pharmaceutical solutions.
Conclusion
Timothy Frank Ryder's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his commitment to improving health outcomes. His work continues to impact the treatment of significant health conditions.